Additionally, Keap1f/f neonatal mice are protected from hypoalveolarization induced by more prolonged hyperoxia (96 h) implying that targeting Keap1 to broadly activate Nrf2 target gene expression may provide novel means to mitigate the incidence of BPD associated with prematurity. The gene discussed is KEAP1; the disease is bronchopulmonary dysplasia.